Literature DB >> 12586318

Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.

Erika Baldaszti1, Beate Wimmer-Puchinger, Kathleen Löschke.   

Abstract

This study investigated the long-term acceptability of a levonorgestrel-releasing intrauterine system (LNG-IUS) in 165 women after 6 and 36 months of use. Changes in menstrual bleeding pattern were experienced by 161 (98%) women, with a cessation or transient absence of menstruation occurring in 75 (47%) and 14 (9%) women, respectively. Amenorrhea was considered by most women (81%) as a positive change. The proportion of women with menstrual pain was reduced from 60% before use to 29% after 36 months of use with the LNG-IUS. Fear of an unwanted pregnancy became less widespread with duration of use and the device had no disturbing effects on the women or their partners during sexual intercourse. The number of women expressing that they were very satisfied with the LNG-IUS was 69% and 77% after six months and 36 months of use, respectively. LNG-IUS is a well-accepted contraceptive method, without negative influences on the sexual relationship between users and their partners, and is suitable for women requiring long-term reversible contraceptive protection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586318     DOI: 10.1016/s0010-7824(02)00482-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  19 in total

Review 1.  Diagnosis and management of dysmenorrhoea.

Authors:  Michelle Proctor; Cynthia Farquhar
Journal:  BMJ       Date:  2006-05-13

2.  Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding.

Authors:  P Warner; A Guttinger; A F Glasier; R J Lee; S Nickerson; R M Brenner; H O D Critchley
Journal:  Hum Reprod       Date:  2009-11-07       Impact factor: 6.918

Review 3.  Dysmenorrhoea.

Authors:  Pallavi Manish Latthe; Rita Champaneria; Khalid Saeed Khan
Journal:  BMJ Clin Evid       Date:  2011-02-21

Review 4.  Dysmenorrhoea.

Authors:  Pallavi Manish Latthe; Rita Champaneria
Journal:  BMJ Clin Evid       Date:  2014-10-21

5.  Immediate postabortion intrauterine device insertion: continuation and satisfaction.

Authors:  Colleen McNicholas; Taylor Hotchkiss; Tessa Madden; Qiuhong Zhao; Jenifer Allsworth; Jeffrey F Peipert
Journal:  Womens Health Issues       Date:  2012 Jul-Aug

Review 6.  Efficacy and safety of long-acting reversible contraception.

Authors:  Amy Stoddard; Colleen McNicholas; Jeffrey F Peipert
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

7.  Three-year continuation of reversible contraception.

Authors:  Justin T Diedrich; Qiuhong Zhao; Tessa Madden; Gina M Secura; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2015-08-07       Impact factor: 8.661

8.  Cost effectiveness of contraceptives in the United States.

Authors:  James Trussell; Anjana M Lalla; Quan V Doan; Eileen Reyes; Lionel Pinto; Joseph Gricar
Journal:  Contraception       Date:  2008-09-25       Impact factor: 3.375

Review 9.  Dysmenorrhea in adolescents: diagnosis and treatment.

Authors:  Linda French
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.

Authors:  Megan N Beatty; Paul D Blumenthal
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.